452 related articles for article (PubMed ID: 22560299)
41. Safety and efficacy of allopurinol in chronic kidney disease.
Thurston MM; Phillips BB; Bourg CA
Ann Pharmacother; 2013 Nov; 47(11):1507-16. PubMed ID: 24259601
[TBL] [Abstract][Full Text] [Related]
42. Gouty arthritis. A primer on late-onset gout.
Ene-Stroescu D; Gorbien MJ
Geriatrics; 2005 Jul; 60(7):24-31. PubMed ID: 16026179
[TBL] [Abstract][Full Text] [Related]
43. Difficult-to-treat gouty arthritis: a disease warranting better management.
Schlesinger N
Drugs; 2011 Jul; 71(11):1413-39. PubMed ID: 21812506
[TBL] [Abstract][Full Text] [Related]
44. Update on emerging urate-lowering therapies.
Chohan S; Becker MA
Curr Opin Rheumatol; 2009 Mar; 21(2):143-9. PubMed ID: 19339925
[TBL] [Abstract][Full Text] [Related]
45. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
[TBL] [Abstract][Full Text] [Related]
46. Febuxostat--treatment for hyperuricemia and gout?
Moreland LW
N Engl J Med; 2005 Dec; 353(23):2505-7. PubMed ID: 16339099
[No Abstract] [Full Text] [Related]
47. Comparison of febuxostat and allopurinol for hyperuricemia in cardiac surgery patients with chronic kidney disease (NU-FLASH trial for CKD).
Sezai A; Soma M; Nakata K; Osaka S; Ishii Y; Yaoita H; Hata H; Shiono M
J Cardiol; 2015 Oct; 66(4):298-303. PubMed ID: 25649025
[TBL] [Abstract][Full Text] [Related]
48. Therapeutic Strategies for the Treatment of Chronic Hyperuricemia: An Evidence-Based Update.
Cicero AFG; Fogacci F; Kuwabara M; Borghi C
Medicina (Kaunas); 2021 Jan; 57(1):. PubMed ID: 33435164
[TBL] [Abstract][Full Text] [Related]
49. Gouty Arthritis: A Review of Acute Management and Prevention.
Wilson L; Saseen JJ
Pharmacotherapy; 2016 Aug; 36(8):906-22. PubMed ID: 27318031
[TBL] [Abstract][Full Text] [Related]
50. Multiple Gouty Tophi with Bone Erosion and Destruction: A Report of an Early-onset Case in an Obese Patient.
D Hayashi R; Yamaoka M; Nishizawa H; Fukuda S; Fujishima Y; Kimura T; Kozawa J; Kita S; Matsuoka TA; Otsuki M; Imagawa A; Ichida K; Taniguchi A; Maeda N; Funahashi T; Shimomura I
Intern Med; 2017; 56(9):1071-1077. PubMed ID: 28458315
[TBL] [Abstract][Full Text] [Related]
51. [Hyperuricemia and kidney damage in patients with cardiovascular disease: A review].
Mironova OI
Ter Arkh; 2023 Jan; 94(12):1426-1430. PubMed ID: 37167189
[TBL] [Abstract][Full Text] [Related]
52. Management of gout: a 57-year-old man with a history of podagra, hyperuricemia, and mild renal insufficiency.
Shmerling RH
JAMA; 2012 Nov; 308(20):2133-41. PubMed ID: 23188030
[TBL] [Abstract][Full Text] [Related]
53. The current state of care in gout: Addressing the need for better understanding of an ancient disease.
Zychowicz ME; Pope RS; Graser E
J Am Acad Nurse Pract; 2010 Nov; 22 Suppl 1():623-36. PubMed ID: 21054636
[TBL] [Abstract][Full Text] [Related]
54. Evaluation and treatment of gout as a chronic disease.
Perez-Ruiz F; Herrero-Beites AM
Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
[TBL] [Abstract][Full Text] [Related]
55. Treatment failure gout.
Ali S; Lally EV
Med Health R I; 2009 Nov; 92(11):369-71. PubMed ID: 19999896
[No Abstract] [Full Text] [Related]
56. Management and Cure of Gouty Arthritis.
Keller SF; Mandell BF
Rheum Dis Clin North Am; 2022 May; 48(2):479-492. PubMed ID: 35400373
[TBL] [Abstract][Full Text] [Related]
57. [Using the whole arsenal to prevent an attack].
Füeßl HS; Stiefelhagen P
MMW Fortschr Med; 2015 Nov; 157(20):22. PubMed ID: 26977497
[No Abstract] [Full Text] [Related]
58. Gouty arthritis: understanding the disease state and management options in primary care.
Sunkureddi P
Adv Ther; 2011 Sep; 28(9):748-60. PubMed ID: 21894471
[TBL] [Abstract][Full Text] [Related]
59. Factors associated with achieving target serum uric acid level and occurrence of gouty arthritis: A retrospective observational study of Japanese health insurance claims data.
Koto R; Nakajima A; Horiuchi H; Yamanaka H
Pharmacoepidemiol Drug Saf; 2021 Feb; 30(2):157-168. PubMed ID: 32939919
[TBL] [Abstract][Full Text] [Related]
60. Progress in the pharmacotherapy of gout.
Sundy JS
Curr Opin Rheumatol; 2010 Mar; 22(2):188-93. PubMed ID: 20110792
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
